Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-κB.
about
iASPP overexpression is associated with clinical outcome in spinal chordoma and influences cellular proliferation, invasion, and sensitivity to cisplatin in vitro.CDK1 interacts with iASPP to regulate colorectal cancer cell proliferation through p53 pathway.Mild Therapeutic Hypothermia Protects the Brain from Ischemia/Reperfusion Injury through Upregulation of iASPP.
P2860
Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-κB.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-κB.
@ast
Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-κB.
@en
type
label
Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-κB.
@ast
Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-κB.
@en
prefLabel
Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-κB.
@ast
Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-κB.
@en
P2093
P2860
P356
P1433
P1476
Caspase cleavage of iASPP potentiates its ability to inhibit p53 and NF-κB.
@en
P2093
Caroline Baer
Elizabeth A Slee
Gopinath Sutendra
Kunming Zhao
Xingwen Wang
Zinaida Dedeić
P2860
P304
42478-42490
P356
10.18632/ONCOTARGET.6478
P407
P577
2015-12-05T00:00:00Z